This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. Its structure, featuring a cyclopropylamine group and difluorophenyl moiety, makes it a valuable intermediate in the creation of molecules targeting central nervous system disorders. Researchers often explore its potential in designing inhibitors for specific enzymes or receptors involved in neurological pathways. Additionally, its unique chemical properties allow for further derivatization, enabling the development of compounds with enhanced bioavailability or therapeutic efficacy. It is also investigated for its role in modulating serotonin or dopamine systems, which could lead to advancements in treating conditions like depression, anxiety, or Parkinson's disease.